Living with HIV involves more than just taking medication—it's about managing your health day-to-day, often while facing stigma. A new study tested whether a special program could help. Researchers worked with 64 Thai men who have sex with men and are living with HIV. Half received their usual care, while the other half also joined a culturally adapted program: four group sessions over seven weeks, led by a nurse and supported by peers. The goal was to build skills and confidence in managing their HIV. After 12 weeks, the men in the program showed greater improvements than the usual-care group. Their CD4 counts (a key measure of immune health) improved more, they reported better adherence to their antiretroviral therapy (ART), their quality of life scores went up, and they felt more capable of managing their HIV. No one reported any harm from the program. This is encouraging—it suggests that adding this kind of supportive, group-based learning to routine care could make a real difference in how people live with HIV. But it's important to keep these results in perspective. The study was small, and we only saw what happened over three months. We don't know if these improvements last longer, or if they translate into harder health outcomes like keeping the virus fully suppressed. The study also didn't detail exactly how they measured medication adherence. So, while this program shows real promise as a potential model, especially in places with limited resources, we need larger studies that follow people for longer to know how well it truly works.
Can group support help men with HIV manage their health better?
Photo by Martin Sanchez / Unsplash
What this means for you:
Group support helped men with HIV improve health markers in a small, short-term study. More on HIV
Agricultural livelihood intervention reduced food insecurity among food insecure women with HIV in Kenya Training women in farming skills reduced hunger for pregnant and non-pregnant HIV patients in Kenya
· May 1, 2026
Tenofovir Disoproxil Fumarate in Maternal ART Linked to Modest Creatinine Decline in HIV-Positive Women Women on TDF-based HIV meds showed kidney changes compared to infant-only treatment
· May 1, 2026
Target trial emulation in Johannesburg shows dolutegravir associated with greater weight and blood pressure increases versus efavirenz New HIV drug linked to higher weight and blood pressure in South Africa
· May 1, 2026
Systematic review and meta-analysis finds subtyping methods linked to HIV recombinant form prevalence New HIV variants hide in plain sight due to testing limits
· May 1, 2026